iX Biopharma (42C.SI) Earnings Analysis
iX Biopharma (42C.SI) next reports earnings on 2026-08-24. Trailing P/E -58.96.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 42C.SI next report earnings?
| Next earnings date | 2026-08-24 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
42C.SI earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2024-12-30 | -0.00717 SGD | n/a | n/a | n/a |
| 2024-08-23 | -0.0046 SGD | n/a | n/a | n/a |
42C.SI valuation and analyst view
| Trailing P/E | -58.96 |
|---|---|
| Trailing EPS | -0.00485 SGD |
| Price / book | 94.63 |
| Dividend yield | 0.00% |
| Market cap | 0.43B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is iX Biopharma (42C.SI)'s next earnings date?
iX Biopharma is next scheduled to report on 2026-08-24.
Did 42C.SI beat earnings last quarter?
Consensus estimate data was not available for 42C.SI's 2024-12-30 report.
What is 42C.SI's current P/E ratio and EPS?
42C.SI trades at a trailing P/E of -58.96 on trailing EPS of -0.0048535406008212755 SGD.
What do analysts rate 42C.SI?
42C.SI has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.